To achieve our mission, we have assembled a team of multi-disciplinary experts and built a culture that values collaboration and a diversity of perspectives and ideas.
Our team is united by our collective desire to develop a novel class of therapeutics for patients suffering from depression, which we believe is linked to disruption of the microbiome of the brain.